Latest Commercialization News

Cauldron Energy’s latest groundwater analysis at the Yanrey Uranium Project reveals low chloride and sulphate levels, affirming the site’s suitability for environmentally friendly in situ recovery uranium mining. This milestone supports the company’s plans to expand resources and advance towards production.

Botala Energy has raised A$3 million through an oversubscribed placement to fully fund drilling and flow testing at its Serowe coal bed methane project this quarter, advancing its commercial gas ambitions.

BPM Minerals has revealed significant soil sampling results at its Forelands Gold Project in Western Australia, identifying multiple untested gold-in-soil anomalies. The company is poised to recommence reverse circulation drilling in early March 2026 to test these promising targets and extend known high-grade mineralisation.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

Larvotto Resources continues to deliver robust drilling results at its Freehold prospect, revealing significant gold, antimony, and tungsten mineralisation that bolsters the Hillgrove Project’s growth outlook.

ION Video Ltd has strengthened its board with the return of its original inventor, Finbar O’Hanlon, alongside CEO Anthony Baker, as the company pivots to become foundational infrastructure for Video Superintelligence.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Iondrive Limited has demonstrated over 85% silver extraction efficiency using its IONSolv™ technology, marking a significant step forward in recycling end-of-life solar panels in Australia.

Hammer Metals has submitted a Mining Lease Application for its Orelia North gold deposit in Western Australia, aiming to accelerate development amid a buoyant gold price. Recent drilling results extend mineralisation, supporting resource growth ahead of a planned 2026 upgrade.

Island Pharmaceuticals secures FDA confirmation on Galidesivir’s development under the Animal Rule, unlocking a streamlined two-stage approval process and significant commercial incentives.

GCM Corporation is advancing its commercialisation strategy with multiple prototypes across key global markets and sectors, aiming for revenue in the first half of 2026.